A French-American research team discovered that the investigational compound Carba1 may prevent chemotherapy-induced peripheral neuropathy (CIPN) in preclinical models. According to a study published ...

FDA IND clearance enables a phase 1b evaluation of SP16 in chemotherapy-induced pain and peripheral neuropathy, with enrollment planned for mid-2026 at the University of Virginia. Proposed mechanisms ...

Chemotherapy has long forced patients to choose between fighting their cancer and living with nerve pain that can linger for years after treatment ends. Now a wave of basic science and early clinical ...

UB researchers are studying how chemotherapy drug MMAE causes peripheral neuropathy, aiming to identify genetic and protein ...

Patients who had low levels of vitamin D before starting chemotherapy tended to have higher rates of chemotherapy-induced peripheral neuropathy, but more research is needed in this field. Patients who ...

Cryotherapy is emerging as a promising, low-risk approach to combat chemotherapy-induced peripheral neuropathy, a common and potentially devastating toxicity of chemotherapy. A growing body of ...

Guard 01: A randomized, multicentre, controlled trail on the prophylactic use of efbemalenograstim alfa for concurrent chemo-radiotherapy induced neutropenia. LOOP: An observational, prospective, ...

CINCINNATI (WKRC) - A drug to fight cancer made right in the Tri-State is now in trials all across the country. It's called BXQ-350 and its now in clinical trials to potentially have a dual purpose - ...

Please provide your email address to receive an email when new articles are posted on . Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event ...